A Study of GC101 TIL in Advanced Solid Tumors (TR)

NCT04967833 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

BIOLOGICAL: Tumor Infiltrating Lymphocytes (TIL)

Sponsor

Shanghai Juncell Therapeutics

Collaborators

[object Object]